About Us
At SARKKOS Therapeutics, our commitment to rigorous and innovative science is matched by our engagement to improve patients’ quality of life. Our close team has diverse professional experiences across the biotech and research ecosystem and strategic innovation, ensuring a holistic approach to advancing groundbreaking therapies and transforming patient outcomes.
Renaud Quantin (PhD, MBA, MIB, Cert.IP)
Chief Executive Officer
Dominic De Nardo (PhD)
External Research Collaborator
Group Leader: Monash University